Unmodified mRNA in LNPs constitutes a competitive technology for prophylactic vaccines (Q47142027)

From Wikidata

Jump to navigation Jump to search

scientific article published on 19 October 2017

Unmodified mRNA in LNPs constitutes a competitive technology for prophylactic vaccines

Language	Label	Description	Also known as
English	Unmodified mRNA in LNPs constitutes a competitive technology for prophylactic vaccines	scientific article published on 19 October 2017	Unmodified mRNA in LNPs constitutes a competitive technology for prophylactic vaccines

Statements

scholarly article

1 reference

Europe PubMed Central

9 January 2018

http://europepmc.org/abstract/PMC/5648897

Unmodified mRNA in LNPs constitutes a competitive technology for prophylactic vaccines (English)

1 reference

Europe PubMed Central

9 January 2018

http://europepmc.org/abstract/PMC/5648897

prophylactic vaccine

1 reference

based on heuristic

inferred from title

Mariola Fotin-Mleczek

11

object named as

Mariola Fotin-Mleczek

1 reference

Europe PubMed Central

9 January 2018

http://europepmc.org/abstract/PMC/5648897

6

object named as

Barbara L Mui

1 reference

Europe PubMed Central

9 January 2018

http://europepmc.org/abstract/PMC/5648897

Regina Heidenreich

10

object named as

Regina Heidenreich

1 reference

Europe PubMed Central

9 January 2018

http://europepmc.org/abstract/PMC/5648897

author name string

Johannes Lutz

1

1 reference

Europe PubMed Central

9 January 2018

http://europepmc.org/abstract/PMC/5648897

Sandra Lazzaro

2

1 reference

Europe PubMed Central

9 January 2018

http://europepmc.org/abstract/PMC/5648897

Mohamed Habbeddine

3

1 reference

Europe PubMed Central

9 January 2018

http://europepmc.org/abstract/PMC/5648897

Kim Ellen Schmidt

4

1 reference

Europe PubMed Central

9 January 2018

http://europepmc.org/abstract/PMC/5648897

Patrick Baumhof

5

1 reference

Europe PubMed Central

9 January 2018

http://europepmc.org/abstract/PMC/5648897

Ying K Tam

7

1 reference

Europe PubMed Central

9 January 2018

http://europepmc.org/abstract/PMC/5648897

Thomas D Madden

8

1 reference

Europe PubMed Central

9 January 2018

http://europepmc.org/abstract/PMC/5648897

Michael J Hope

9

1 reference

Europe PubMed Central

9 January 2018

http://europepmc.org/abstract/PMC/5648897

publication date

19 October 2017

1 reference

Europe PubMed Central

9 January 2018

http://europepmc.org/abstract/PMC/5648897

1 reference

Europe PubMed Central

9 January 2018

http://europepmc.org/abstract/PMC/5648897

2

1 reference

Europe PubMed Central

9 January 2018

http://europepmc.org/abstract/PMC/5648897

29

1 reference

Europe PubMed Central

9 January 2018

http://europepmc.org/abstract/PMC/5648897

1

0 references

copyright license

Creative Commons Attribution 4.0 International

19 October 2017

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

https://scigraph.springernature.com/pub.10.1038/s41541-017-0032-6

0 references

Vaccine Mediated Protection Against Zika Virus-Induced Congenital Disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5648897

23 May 2018

Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5648897

23 May 2018

Modified mRNA Vaccines Protect against Zika Virus Infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5648897

23 May 2018

Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5648897

23 May 2018

An mRNA Vaccine Encoding Rabies Virus Glycoprotein Induces Protection against Lethal Infection in Mice and Correlates of Protection in Adult and Newborn Pigs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5648897

23 May 2018

From the RNA world to the clinic

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5648897

23 May 2018

Self-adjuvanted mRNA vaccines induce local innate immune responses that lead to a potent and boostable adaptive immunity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5648897

23 May 2018

Recent innovations in mRNA vaccines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5648897

23 May 2018

mRNA vaccine delivery using lipid nanoparticles

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5648897

23 May 2018

N(1)-methylpseudouridine-incorporated mRNA outperforms pseudouridine-incorporated mRNA by providing enhanced protein expression and reduced immunogenicity in mammalian cell lines and mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5648897

23 May 2018

Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5648897

23 May 2018

Sequence-engineered mRNA Without Chemical Nucleoside Modifications Enables an Effective Protein Therapy in Large Animals

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5648897

23 May 2018

Potent immune responses in rhesus macaques induced by nonviral delivery of a self-amplifying RNA vaccine expressing HIV type 1 envelope with a cationic nanoemulsion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5648897

23 May 2018

A cationic nanoemulsion for the delivery of next-generation RNA vaccines.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5648897

23 May 2018

Circumventing antivector immunity: potential use of nonhuman adenoviral vectors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5648897

23 May 2018

The who's who of T-cell differentiation: human memory T-cell subsets

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5648897

23 May 2018

Innate immunity and vaccines.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5648897

23 May 2018

A novel, disruptive vaccination technology: self-adjuvanted RNActive(®) vaccines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5648897

23 May 2018

Biodegradable lipids enabling rapidly eliminated lipid nanoparticles for systemic delivery of RNAi therapeutics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5648897

23 May 2018

Accelerating next-generation vaccine development for global disease prevention

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5648897

23 May 2018

Designing tomorrow's vaccines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5648897

23 May 2018

Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5648897

23 May 2018

Nonviral delivery of self-amplifying RNA vaccines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5648897

23 May 2018

Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5648897

23 May 2018

CXCR3 ligands: redundant, collaborative and antagonistic functions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5648897

23 May 2018

DNA vaccines against cancer come of age.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5648897

23 May 2018

Vaccines: correlates of vaccine-induced immunity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5648897

23 May 2018

T-cell quality in memory and protection: implications for vaccine design

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5648897

23 May 2018

Vaccination with messenger RNA (mRNA).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5648897

23 May 2018

Vaccination with messenger RNA.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5648897

23 May 2018

Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5648897

23 May 2018

In vivo application of RNA leads to induction of specific cytotoxic T lymphocytes and antibodies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5648897

23 May 2018

Safety and efficacy of RNAi therapy for transthyretin amyloidosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5648897

15 August 2018

Messenger RNA-based vaccines with dual activity induce balanced TLR-7 dependent adaptive immune responses and provide antitumor activity.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5648897

15 August 2018

Identifiers

10.1038/S41541-017-0032-6

1 reference

Europe PubMed Central

9 January 2018

http://europepmc.org/abstract/PMC/5648897

1 reference

Europe PubMed Central

9 January 2018

http://europepmc.org/abstract/PMC/5648897

1 reference

Europe PubMed Central

9 January 2018

http://europepmc.org/abstract/PMC/5648897

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47142027&oldid=2142868332"